Impact of medical therapy on transurethral resection of the prostate: two decades of change - Izard, Jason; Nickel, J. Curtis (BJU international, 2011)
Keywords: 5-alpha Reductase Inhibitors - therapeutic use; 5‐alpha reductase therapy; Adrenergic alpha-Antagonists - therapeutic use; Aged; alpha blocker; benign prostatic hyperplasia; Biological and medical sciences; Drug Therapy, Combination - methods; Epidemiologic Methods; Gynecology. Andrology. Obstetrics; Humans; Length of Stay; lower urinary tract symptoms; Male; Male genital diseases; Medical sciences; medical therapy; Middle Aged; Nephrology. Urinary tract diseases; Postoperative Complications - etiology; Prostatic Hyperplasia - complications; Prostatic Hyperplasia - therapy; Prostatism - drug therapy; Prostatism - etiology; Prostatism - surgery; Transurethral Resection of Prostate - adverse effects; Transurethral Resection of Prostate - trends; transurethral resection of the prostate; Treatment Outcome; Tumors; Tumors of the urinary system; Urinary Catheterization; Urinary tract. Prostate gland; Nephrology; Prostate disease; medical therapy; Transurethral route; Urology; Voiding dysfunction; Surgery; Benign prostatic hyperplasia; Benign neoplasm; Urogenital system; Male genital diseases; Lower urinary tract symptoms; Urinary system disease; Enzyme; transurethral resection of the prostate; Surgical resection; Urinary tract disease; Medicine; Treatment; 5-alpha reductase therapy; Surgical approach; Oxidoreductases; Prostate; Reductase; alpha blocker